Steroids as γ-secretase modulators

FASEB Journal

Volumn 27, Issue 9, 2013, Pages 3775-3785

  Jung, Joo In ^a   Ladd, Thomas B ^a   Kukar, Thomas ^b   Price, Ashleigh R ^a   Moore, Brenda D ^a   Koo, Edward H ^c   Golde, Todd E ^a   Felsenstein, Kevin M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A ; Alzheimer's disease; Amyloid; Cholesterol metabolites

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHOLANIC ACID; CHOLANIC ACID DERIVATIVE; ESTROGEN; GAMMA SECRETASE; LITHOCHOLIC ACID; PROGESTERONE; STEROID; STEROID HORMONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STRUCTURE ACTIVITY RELATION;

AΒ; ALZHEIMER'S DISEASE; AMYLOID; CHOLESTEROL METABOLITES;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL LINE; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; HUMANS; MASS SPECTROMETRY; PROGESTERONE; STEROIDS;

EID: 84883443175     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-225649     Document Type: Article

References (65)

1. Golde, T. E., Eckman, C. B., and Younkin, S. G. (2000) Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta 1502, 172-187
2. Teller, J. K., Russo, C., DeBusk, L. M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartezzini, P., Bertolini, S., Mann, D. M., Tabaton, M., and Gambetti, P. (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2, 93-95
3. Russo, C., Saido, T. C., DeBusk, L. M., Tabaton, M., Gambetti, P., and Teller, J. K. (1997) Heterogeneity of water-soluble amyloid α-peptide in Alzheimer's disease and Down's syndrome brains. FEBS Lett. 409, 411-416
4. Moore, B., Chakrabarty, P., Levites, Y., Kukar, T., Baine, A.-M., Moroni, T., Ladd, T., Das, P., Dickson, D., and Golde, T. (2012) Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains. Alzheimers Res. Ther. 4, 18
5. Wang, R., Sweeney, D., Gandy, S., and Sisodia, S. (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271, 31894-31902
6. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. (1992) Isolation and quantification of soluble Alzheimer's α-peptide from biological fluids. Nature 359, 325-327
7. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., and Younkin, S. G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336-1340
8. Steven G, Y. The role of Aα42 in Alzheimer's disease. J. Physiol. 92, 289-292
9. Jarret, J. T. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implication for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697
10. Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., and Younkin, S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7016
11. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aα42(43). Neuron 13, 45-53
12. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., DeLucia, M., Lin, W.-L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., and Golde, T. (2005) Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199
13. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., and McGowan, E. (2007) Aα40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633
14. Wang, R., Wang, B., He, W., and Zheng, H. (2006) Wild-type presenilin 1 protects against alzheimer disease mutation-induced amyloid pathology. J. Biol. Chem. 281, 15330-15336
15. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., Kang, D. E., Marquez-Sterling, N., Golde, T. E., and Koo, E. H. (2001) A subset of NSAIDs lower amyloidogenic Aα42 independently of cyclooxygenase activity. Nature 414, 212-216
16. Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., and Golde, T. E. (2003) NSAIDs and enantiomers of flurbiprofen target α-secretase and lower Aα42 in vivo. J. Clin. Invest. 112, 440-449
17. Kukar, T., and Golde, T. E. (2008) Possible mechanisms of action of NSAIDs and related compounds that modulate gamma- secretase cleavage. Curr. Top. Med. Chem. 8, 47-53
18. Zall, A., Kieser, D., Höttecke, N., Naumann, E. C., Thomaszewski, B., Schneider, K., Steinbacher, D. T., Schubenel, R., Masur, S., Baumann, K., and Schmidt, B. (2011) NSAID-derived α-secretase modulation requires an acidic moiety on the carbazole scaffold. Bioorg. Med. Chem. 19, 4903-4909
19. Oehlrich, D., Berthelot, D. J. C., and Gijsen, H. J. M. (2010) γ-Secretase modulators as potential disease modifying antialzheimer's drugs. J. Med. Chem. 54, 669-698
20. Kukar, T., Murphy, M. P., Eriksen, J. L., Sagi, S. A., Weggen, S., Smith, T. E., Ladd, T., Khan, M. A., Kache, R., Beard, J., Dodson, M., Merit, S., Ozols, V. V., Anastasiadis, P. Z., Das, P., Fauq, A., Koo, E. H., and Golde, T. E. (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aα42 production. Nat. Med. 11, 545-550
21. Sagi, S. A., Lessard, C. B., Winden, K. D., Maruyama, H., Koo, J. C., Weggen, S., Kukar, T. L., Golde, T. E., and Koo, E. H. (2011) Substrate sequence influences α-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein. J. Biol. Chem. 286, 39794-39803
22. Hall, A., Elliott, R. L., Giblin, G. M., Hussain, I., Musgrave, J., Naylor, A., Sasse, R., and Smith, B. (2010) Piperidine-derived gamma-secretase modulators. Bioorg. Med. Chem. Lett. 20, 1306- 1311
23. Rivkin, A., Ahearn, S. P., Chichetti, S. M., Kim, Y. R., Li, C., Rosenau, A., Kattar, S. D., Jung, J., Shah, S., Hughes, B. L., Crispino, J. L., Middleton, R. E., Szewczak, A. A., Munoz, B., and Shearman, M. S. (2010) Piperazinyl pyrimidine derivatives as potent α-secretase modulators. Bioorg. Med. Chem. Lett. 20, 1269-1271
24. Gijsen, H. J., and Mercken, M. (2012) α-Secretase modulators: can we combine potency with safety? Int. J. Alzheimers Dis. 2012, 295207
25. Tognolini, M., Incerti, M., Hassan-Mohamed, I., Giorgio, C., Russo, S., Bruni, R., Lelli, B., Bracci, L., Noberini, R., Pasquale, E. B., Barocelli, E., Vicini, P., Mor, M., and Lodola, A. (2012) Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor. Chem. Med. Chem. 7, 1071-1083
26. Fukuchi, J., Song, C., Dai, Q., Hiipakka, R. A., and Liao, S. (2005) 5β-Cholane activators of the farnesol X receptor. J. Steroid Biochem. Mol. Biol. 94, 311-318
27. Suzuki, T., Tamehiro, N., Sato, Y., Kobayashi, T., Ishii-Watabe, A., Shinozaki, Y., Nishimaki-Mogami, T., Hashimoto, T., Asakawa, Y., Inoue, K., Ohno, Y., Yamaguchi, T., and Kawanishi, T. (2008) The novel compounds that activate farnesoid X receptor: the diversity of their effects on gene expression. J. Pharm. Sci. 107, 285-294
28. Amtul, Z., Wang, L., Westaway, D., and Rozmahel, R. F. (2010) Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169, 781-786
29. Murphy, M. P., Uljon, S. N., Fraser, P. E., Fauq, A., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., and Golde, T. E. (2000) Presenilin 1 regulates pharmacologically distinct α-secretase activities: implications for the role of presenilin in α-secretase cleavage. J. Biol. Chem. 275, 26277-26284
30. Barltrop, J A., Owen, T. C., Cory, A. H., and Cory, J. G. (1991) 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4- sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)- 2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg. Med. Chem. Lett. 1, 611-614
31. Fraering, P. C., Ye, W., Strub, J. M., Dolios, G., LaVoie, M. J., Ostaszewski, B. L., van Dorsselaer, A., Wang, R., Selkoe, D. J., Wolfe, M. S. (2004) Purification and characterization of the human gamma-secretase complex. Biochemistry 43, 9774-9789
32. McLendon, C., Xin, T., Ziani-Cherif, C., Murphy, M. P., Findlay, K. A., Lewis, P. A., Pinnix, I., Sambamurti, K., Wang, R., Fauq, A., and Golde, T. E. (2000) Cell-free assays for α-secretase activity. FASEB J. 14, 2383-2386
33. Lessard, C., Tyan, S.-H., Maruyama, H., Cottrell, Suresh, S., Golde, T., and Koo, E. (2012) γ-Secretase modulators do not alter ε-cleavage of APP in modulating Aβ42 levels. Soc. Neurosci. Ann. Meet. 750.27, E66
34. Li, X., Dang, S., Yan, C., Gong, X., Wang, J., and Shi, Y. (2013) Structure of a presenilin family intramembrane aspartate protease. Nature 493, 56-61
35. De Strooper, B., Iwatsubo, T., and Wolfe, M. S. (2012) Presenilins and α-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006304
36. Kukar, T. L., Ladd, T. B., Bann, M. A., Fraering, P. C., Narlawar, R., Maharvi, G. M., Healy, B., Chapman, R., Welzel, A. T., Price, R. W., Moore, B., Rangachari, V., Cusack, B., Eriksen, J., Jansen-West, K., Verbeeck, C., Yager, D., Eckman, C., Ye, W., Sagi, S., Cottrell, B. A., Torpey, J., Rosenberry, T. L., Fauq, A., Wolfe, M. S., Schmidt, B., Walsh, D. M., Koo, E. H., and Golde, T. E. (2008) Substrate-targeting [ggr]-secretase modulators. Nature 453, 925-929
37. Richter, L., Munter, L.-M., Ness, J., Hildebrand, P. W., Dasari, M., Unterreitmeier, S., Bulic, B., Beyermann, M., Gust, R., Reif, B., Weggen, S., Langosch, D., and Multhaup, G. (2010) Amyloid beta 42 peptide (Aα42)-lowering compounds directly bind to Aβ and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc. Natl. Acad. Sci. U. S. A. 107, 14597-14602
38. Ebke, A., Luebbers, T., Fukumori, A., Shirotani, K., Haass, C., Baumann, K., and Steiner, H. (2011) Novel α-secretase enzyme modulators directly target presenilin protein. J. Biol. Chem. 286, 37181-37186
39. Kounnas, M. Z., Danks, A. M., Cheng, S., Tyree, C., Ackerman, E., Zhang, X., Ahn, K., Nguyen, P., Comer, D., Mao, L., Yu, C., Pleynet, D., Digregorio, P. J., Velicelebi, G., Stauderman, K. A., Comer, W. T., Mobley, W. C., Li, Y.-M., Sisodia, S. S., Tanzi, R. E., and Wagner, S. L. (2010) Modulation of α-secretase reduces α-amyloid deposition in a transgenic mouse model of alzheimer's disease. Neuron 67, 769-780
40. Ohki, Y., Higo, T., Uemura, K., Shimada, N., Osawa, S., Berezovska, O., Yokoshima, S., Fukuyama, T., Tomita, T., and Iwatsubo, T. (2011) Phenylpiperidine-type α-secretase modulators target the transmembrane domain 1 of presenilin 1. EMBO J. 30, 4815-4824
41. Crump, C. J., Fish, B. A., Castro, S. V., Chau, D.-M., Gertsik, N., Ahn, K., Stiff, C., Pozdnyakov, N., Bales, K. R., Johnson, D. S., and Li, Y.-M. (2011) Piperidine acetic acid based α-secretase modulators directly bind to presenilin-1. ACS Chem. Neurosci. 2, 705-710
42. Kukar, T. L., Ladd, T. B., Robertson, P., Pintchovski, S. A., Moore, B., Bann, M. A., Ren, Z., Jansen-West, K., Malphrus, K., Eggert, S., Maruyama, H., Cottrell, B. A., Das, P., Basi, G. S., Koo, E. H., and Golde, T. E. (2011) Lysine 624 of the amyloid precursor protein (app) is a critical determinant of amyloid β peptide length. J. Biol. Chem. 286, 39804-39812
43. Bodovitz, S., and Klein, W. L. (1996) Cholesterol modulates secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440
44. Kojro, E., Gimpl, G., Lammich, S., März, W., and Fahrenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 Proc. Natl. Acad. Sci. U. S. A. 98, 5815-5820
45. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of α-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460-6464
46. Wahrle, S., Das, P., Nyborg, A. C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L. H., Younkin, S. G., and Golde, T. E. (2002) Cholesterol-dependent α-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9, 11-23
47. Golde, T. E., and Eckman, C. B. (2001) Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease. Drug Disc. Today 6, 1049-1055
48. Bhattacharyya, R., and Kovacs, D. M. (2010) ACAT inhibition and amyloid beta reduction. Biochim. Biophys. Acta 1801, 960- 965
49. Prasanthi, J., Huls, A., Thomasson, S., Thompson, A., Schommer, E., and Ghribi, O. (2009) Differential effects of 24- hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol. Neurodegener. 4, 1
50. Brown, J. (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279, 34674-34681
51. Nunes, A., Amaral, J., Lo, A., Fonseca, M., Viana, R. S., Callaerts-Vegh, Z., D'Hooge, R., and Rodrigues, C. P. (2012) TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid deposition in APP/PS1 mice. Mol. Neurobiol. 45, 440-454
52. Beel, A. J., Sakakura, M., Barrett, P. J., and Sanders, C. R. (2010) Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta 1801, 975-982
53. Barrett, P. J., Song, Y., Van Horn, W. D., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., Beel, A. J., and Sanders, C. R. (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168-1171
54. Yue, X., Lu, M., Lancaster, T., Cao, P., Honda, S.-I., Staufenbiel, M., Harada, N., Zhong, Z., Shen, Y., and Li, R. (2005) Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 102, 19198-19203
55. Jaffe, A. B., Toran-Allerand, C. D., Greengard, P., and Gandy, S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269, 13065-13068
56. Chang, D., Kwan, J., and Timiras, P. S. (1997) Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. Adv. Exp. Med. Biol. 429, 261-271
57. Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. N., Seeger, M., Relkin, N. R., Liao, F., Checler, F., Buxbaum, J. D., Chait, B. T., Thinakaran, G., Sisodia, S. S., Wang, R., Greengard, P., and Gandy, S. (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4, 447-451
58. Haskell, S. G., Richardson, E. D., and Horwitz, R. I. (1997) The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J. Clin. Epidemiol. 50, 1249-1264
59. Manthey, D., Heck, S., Engert, S., and Behl, C. (2001) Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen-activated protein kinase pathway. Eur J. Biochem. 268, 4285-4291
60. Jayaraman, A., Carroll, J. C., Morgan, T. E., Lin, S., Zhao, L., Arimoto, J. M., Murphy, M. P., Beckett, T. L., Finch, C. E., Brinton, R. D., and Pike, C. J. (2012) 17α-Estradiol and progesterone regulate expression of α-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology 153, 5467-5479
61. Seiffert, D., Bradley, J. D., Rominger, C. M., Rominger, D. H., Yang, F., Meredith, J. E., Wang, Q., Roach, A. H., Thompson, L. A., Spitz, S. M., Higaki, J. N., Prakash, S. R., Combs, A. P., Copeland, R. A., Arneric, S. P., Hartig, P. R., Robertson, D. W., Cordell, B., Stern, A. M., Olson, R. E., and Zaczek, R. (2000) Presenilin-1 and -2 are molecular targets for α-secretase inhibitors. J. Biol. Chem. 275, 34086-34091
62. Klafki, H.-W., Wiltfang, J., and Staufenbiel, M. (1996) Electrophoretic separation of βA4 peptides (1-40) and (1-42). Anal. Biochem. 237, 24-29
63. Popp, J., Lewczuk, P., Kölsch, H., Meichsner, S., Maier, W., Kornhuber, J., Jessen, F., Lütjohann, D. (2012) Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease. Neurochem. 123, 310-316
64. Hubbs, J. L., Fuller, N. O., Austin, W. F., Shen, R., Ruicaho, R., Creaser, S. P., McKee, T. D., Loureiro, R. M. B., Tate, B., Xia, W., Ives, J., and Bronk, B. S. (2012) Optimization of a natural product-based class of α-secretase modulators. J. Med. Chem. 55, 9270-9282
65. Loureiro, R. M., Dumin, J. A., McKee, T. D., Austin, W. F., Fuller, N. O., Hubbs, J. L., Shen, R., Jonker, J., Ives, J., Bronk, BS., Tate, B. (2013) Efficacy of SPI-1865, a novel gammasecretase modulator, in multiple rodent models. Alzheimers Res. Ther. 5, 19